Literature DB >> 18559531

Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion.

Yonghua Yang1, Rehka Rao, Jie Shen, Yun Tang, Warren Fiskus, John Nechtman, Peter Atadja, Kapil Bhalla.   

Abstract

Heat shock protein (hsp) 90 is an ATP-dependent molecular chaperone that maintains the active conformation of client oncoproteins in cancer cells. An isoform, hsp90alpha, promotes extracellular maturation of matrix metalloproteinase (MMP)-2, involved in tumor invasion and metastasis. Knockdown of histone deacetylase (HDAC) 6, which deacetylates lysine residues in hsp90, induces reversible hyperacetylation and attenuates ATP binding and chaperone function of hsp90. Here, using mass spectrometry, we identified seven lysine residues in hsp90alpha that are hyperacetylated after treatment of eukaryotic cells with a pan-HDAC inhibitor that also inhibits HDAC6. Depending on the specific lysine residue in the middle domain involved, although acetylation affects ATP, cochaperone, and client protein binding to hsp90alpha, acetylation of all seven lysines increased the binding of hsp90alpha to 17-allyl-amino-demethoxy geldanamycin. Notably, after treatment with the pan-HDAC inhibitor panobinostat (LBH589), the extracellular hsp90alpha was hyperacetylated and it bound to MMP-2, which was associated with increased in vitro tumor cell invasiveness. Treatment with antiacetylated hsp90alpha antibody inhibited in vitro invasion by tumor cells. Thus, reversible hyperacetylation modulates the intracellular and extracellular chaperone function of hsp90, and targeting extracellular hyperacetylated hsp90alpha may undermine tumor invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559531      PMCID: PMC2665713          DOI: 10.1158/0008-5472.CAN-08-0644

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  The importance of ATP binding and hydrolysis by hsp90 in formation and function of protein heterocomplexes.

Authors:  J P Grenert; B D Johnson; D O Toft
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

2.  The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37).

Authors:  S Mark Roe; Maruf M U Ali; Philippe Meyer; Cara K Vaughan; Barry Panaretou; Peter W Piper; Chrisostomos Prodromou; Laurence H Pearl
Journal:  Cell       Date:  2004-01-09       Impact factor: 41.582

3.  ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo.

Authors:  B Panaretou; C Prodromou; S M Roe; R O'Brien; J E Ladbury; P W Piper; L H Pearl
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

4.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

5.  Potentiation of invasive capacity of rat ascites hepatoma cells by adriamycin.

Authors:  F Imamura; T Horai; M Mukai; K Shinkai; H Akedo
Journal:  Cancer Res       Date:  1990-04-01       Impact factor: 12.701

6.  Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.

Authors:  Prince George; Purva Bali; Srinivas Annavarapu; Anna Scuto; Warren Fiskus; Fei Guo; Celia Sigua; Gautam Sondarva; Lynn Moscinski; Peter Atadja; Kapil Bhalla
Journal:  Blood       Date:  2004-10-28       Impact factor: 22.113

Review 7.  Extracellular roles for the molecular chaperone, hsp90.

Authors:  Brenda K Eustace; Daniel G Jay
Journal:  Cell Cycle       Date:  2004-09-14       Impact factor: 4.534

8.  Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness.

Authors:  Brenda K Eustace; Takashi Sakurai; Jean K Stewart; Dean Yimlamai; Christine Unger; Carol Zehetmeier; Blanca Lain; Claudia Torella; Stefan W Henning; Gerald Beste; Bradley T Scroggins; Len Neckers; Leodevico L Ilag; Daniel G Jay
Journal:  Nat Cell Biol       Date:  2004-05-16       Impact factor: 28.824

9.  Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.

Authors:  B Becker; G Multhoff; B Farkas; P-J Wild; M Landthaler; W Stolz; T Vogt
Journal:  Exp Dermatol       Date:  2004-01       Impact factor: 3.960

10.  Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.

Authors:  Chengkai Dai; Luke Whitesell; Arlin B Rogers; Susan Lindquist
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

View more
  102 in total

1.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

2.  Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells.

Authors:  Rekha Rao; Srilatha Nalluri; Warren Fiskus; Andrew Savoie; Kathleen M Buckley; Kyungsoo Ha; Ramesh Balusu; Atul Joshi; Veena Coothankandaswamy; Jianguo Tao; Eduardo Sotomayor; Peter Atadja; Kapil N Bhalla
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

Review 3.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

Review 4.  Discovery and mechanism of natural products as modulators of histone acetylation.

Authors:  Lilibeth A Salvador; Hendrik Luesch
Journal:  Curr Drug Targets       Date:  2012-07       Impact factor: 3.465

5.  YfmK is an Nε-lysine acetyltransferase that directly acetylates the histone-like protein HBsu in Bacillus subtilis.

Authors:  Valerie J Carabetta; Todd M Greco; Ileana M Cristea; David Dubnau
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

Review 6.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

Review 7.  Regulation, Function, and Detection of Protein Acetylation in Bacteria.

Authors:  Valerie J Carabetta; Ileana M Cristea
Journal:  J Bacteriol       Date:  2017-07-25       Impact factor: 3.490

8.  IIp45 inhibits cell migration through inhibition of HDAC6.

Authors:  Ying Wu; Sonya W Song; Jiyuan Sun; Janet M Bruner; Gregory N Fuller; Wei Zhang
Journal:  J Biol Chem       Date:  2009-12-12       Impact factor: 5.157

Review 9.  Impact of heat-shock protein 90 on cancer metastasis.

Authors:  Shinji Tsutsumi; Kristin Beebe; Len Neckers
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

10.  Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells.

Authors:  Rekha Rao; Pearl Lee; Warren Fiskus; Yonghua Yang; Rajeshree Joshi; Yongchao Wang; Kate Buckley; Ramesh Balusu; Jianguang Chen; Sanjay Koul; Atul Joshi; Sunil Upadhyay; Jianguo Tao; Eduardo Sotomayor; Kapil N Bhalla
Journal:  Cancer Biol Ther       Date:  2009-07       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.